| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
865,460 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,326 |
485,736 |
| Total Sell Value |
$0 |
$0 |
$8,245,949 |
$88,282,436 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
18 |
71 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Drachman Jonathan G |
CMO & EVP, R & D |
• – – |
2018-03-05 |
4 |
OE |
$8.96 |
$93,695 |
D/D |
10,457 |
174,191 |
|
- |
|
| Welch Daniel G |
Director |
– • – |
2018-02-13 |
4 |
OE |
$8.38 |
$158,463 |
D/D |
16,881 |
66,100 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-02-09 |
4 |
AS |
$49.23 |
$936,818 |
D/D |
(18,832) |
687,146 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-02-09 |
4 |
OE |
$11.09 |
$208,847 |
D/D |
18,832 |
697,546 |
|
- |
|
| Cline Darren S |
EVP, Commercial |
• – – |
2018-02-05 |
4 |
D |
$55.58 |
$77,756 |
D/D |
(1,399) |
75,831 |
|
- |
|
| Baker Felix |
Director |
– • • |
2018-02-01 |
4 |
B |
$52.00 |
$199,999,956 |
I/I |
3,846,153 |
44,355,335 |
2.25 |
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-01-11 |
4 |
AS |
$51.47 |
$973,873 |
D/D |
(18,832) |
687,146 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-01-11 |
4 |
OE |
$11.09 |
$208,847 |
D/D |
18,832 |
687,846 |
|
- |
|
| Drachman Jonathan G |
CMO & EVP, R & D |
• – – |
2018-01-11 |
4 |
OE |
$10.61 |
$214,705 |
D/D |
19,416 |
170,934 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2017-12-11 |
4 |
AS |
$53.62 |
$1,043,329 |
D/D |
(18,832) |
687,146 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2017-12-11 |
4 |
OE |
$11.09 |
$208,847 |
D/D |
18,832 |
688,946 |
|
- |
|
| Liu Jean I |
GC/EVP, Leg Affairs |
• – – |
2017-12-04 |
4 |
D |
$59.55 |
$448,769 |
D/D |
(7,536) |
60,864 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2017-12-04 |
4 |
OE |
$26.10 |
$197,300 |
D/D |
6,165 |
119,860 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2017-12-04 |
4 |
S |
$58.75 |
$219,092 |
D/D |
(3,729) |
117,424 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2017-11-30 |
4 |
AS |
$59.84 |
$599,729 |
D/D |
(10,000) |
164,906 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2017-11-30 |
4 |
OE |
$12.00 |
$121,573 |
D/D |
10,000 |
167,337 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2017-11-17 |
4 |
S |
$59.13 |
$591,250 |
D/D |
(10,000) |
117,424 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2017-11-17 |
4 |
OE |
$26.10 |
$261,000 |
D/D |
10,000 |
127,424 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2017-11-16 |
4 |
S |
$57.95 |
$892,637 |
D/D |
(15,400) |
117,424 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2017-11-16 |
4 |
OE |
$15.46 |
$311,617 |
D/D |
15,400 |
125,913 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2017-11-15 |
4 |
S |
$57.80 |
$554,837 |
D/D |
(9,600) |
117,424 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2017-11-15 |
4 |
OE |
$15.46 |
$148,416 |
D/D |
9,600 |
127,024 |
|
- |
|
| Lippman Marc E |
Director |
– • – |
2017-11-15 |
4 |
S |
$58.07 |
$174,224 |
D/D |
(3,000) |
132,050 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2017-11-10 |
4 |
AS |
$57.95 |
$1,092,193 |
D/D |
(18,832) |
687,146 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2017-11-10 |
4 |
OE |
$11.09 |
$208,847 |
D/D |
18,832 |
704,255 |
|
- |
|
1805 Records found
|
|
Page 25 of 73 |
|
|
